期刊文献+

STI571诱导K562细胞凋亡机制研究 被引量:4

The mechanism of STI571 inducing apoptosis of K562 cells
原文传递
导出
摘要 目的 研究格列卫 (Glivec ,STI5 71)诱导P2 10BCR/ABL(+)K5 6 2细胞凋亡机制。方法 采用Annexin Ⅴ /PI双染实验、DNA的PI染色、碘化二己基恶碳菁 (DiOC6 [3])染色、2 ,7 二氯荧光素二乙酸酯 (DCFH DA)染色及DNALadder等方法测定凋亡细胞。利用Westernblot实验分析K5 6 2细胞蛋白酪氨酸磷酸化水平 ,测定Bcl XL、caspase 3蛋白的表达并分别测定线粒体及胞浆部分的细胞色素C(cytoC)蛋白。结果 STI5 71可诱导K5 6 2细胞凋亡 ,出现DNA亚二倍体凋亡峰及DNALadder,线粒体跨膜电位及活性氧物质降低 ,P2 10BCR/ABL酪氨酸磷酸化水平降低 ,Bcl XL、蛋白减少 ,caspase 3蛋白前体活化降解出相对分子质量为 2 0× 10 3 亚单位 ,胞浆部分出现cytoC ,同时线粒体cytoC减少。结论 STI5 71可迅速使P2 10BCR/ABL酪氨酸磷酸化水平下降 ,线粒体cytoC胞浆转位介导的信号通路是STI5 71诱导K5 6 2细胞凋亡的途径之一 ,STI5 Objective To investigate the mechanism of STI571 inducing apoptosis of K562 cells which express P210 BCR/ABL . Methods Apoptosis was analyzed by Annexin V/PI, DioC6 staining, DCFH DA staining, DNA PI staining and DNA ladder. Western blot was used to analyse mitochondrial and cytosolic cyto C, Bcl X L,caspase 3, actin protein and the level of tyrosine phosphorylation. Results After exposure to STI571, K562 cells were induced to apoptosis. Tyrosine phosphorylation level of P210 BCR/ABL and Bcl X L was decreased. Caspase 3 was activated and there was an cytosolic accumulation of cyto C. Conclusion STI571 could rapidly decrease the tyrosine phosphorylation level of P210 BCR/ABL . The signal pathway mediated by the cytosolic translocation of mitochondrial cyto C was one of the mechanisms that STI571 inducing apoptosis. STI571 was an effective gene targeting therapeutic agent.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2002年第6期289-292,共4页 Chinese Journal of Hematology
关键词 STI571 K562细胞 细胞凋亡 格列卫 酪氨酸磷酸化 线粒体 白血病 基因治疗 Glivec Apoptosis Tyrosine phosphorylation Mitochondria
  • 相关文献

参考文献10

  • 1Carroll M,Ohno-Jones S,Tamura S,et al.CGP57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL and TEL-PDGFR fusion proteins[].Blood.1997
  • 2Bass DA,Parce W,Lawrence R,et al.Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation[].J Immunol.1983
  • 3Fennell DA,Cotter FE.Stochastic modeling of apoptosis tolerance distributions measured by multivariate flow analysis of human leukemia cells[].Cytometry.2000
  • 4Sattler M,Verma S,Shrikhande G,et al.The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells[].Journal of Biological Chemistry.2000
  • 5Adams JM,Cory S.The Bcl-2 protein family: arbiters of cell survival[].Science.1998
  • 6Benito A,Silva M,Grilot D,et al.Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-XL[].Blood.1996
  • 7Kroemer G,Zamzami NA,Susin SA.Mitochondrial control of apoptosis[].Immunology Today.1997
  • 8Amarante-Mendes GP,McGahon AJ,Nishioka WK,et al.Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-XL[].Oncegene.1998
  • 9Amarante-Mendes GP,Kim CN,Linda L,et al.Bcr-abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activition of caspase-3[].Blood.1998
  • 10Druker BJ,Lydon NB.Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia[].The Journal of Clinical Investigation.2000

同被引文献24

  • 1Rassidakis G Z, Georgakis G V, Dyaizo M, et al. Lack of c-kit (CD117) expression in CD30+ lymphomas and lymphomatoid papulosis[J]. Mod Pathol, 2004, 17(8) : 946-953.
  • 2Atanasio P, Xonia C V, Soraya T, et al. Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common anti myeloma agents[J]. British Joumal of Haematology, 2003, 123(5): 858-868.
  • 3Aldinucci D, Poletto D, Nanni P, et al. Hodgkin and Reed-Sternberg cells express functional c-kit receptors and interact with primary fibroblasts from Hodgkin's disease-involved lymph nodes through soluble and membrane-bound stem cell factor[J]. Br J Haematol, 2002, 118(4): 1055-1064.
  • 4Brauns T, Schuhewoher T, Dissmond J, et al. C-KIT expression in primary cutaneous T-cell lymphomas[J]. J Cutan Pathol, 2004, 31 : 577-582.
  • 5Gibson S L, Dai C Y, Lee H W, et al. Inhibition of colon tumor progression and angiogenesis by the INK4a/Arf locus[J]. Cancer Res, 2003, 63(4) : 742-746.
  • 6Maesawa C, Tamura G, Nishizuka S, et al. Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma[J]. Cancer Research, 1996, 56: 3875-3878.
  • 7Yamada Y, Kamihira S. Inactivation of tumor suppressor genes and the progression of adult T-cell leukemia-lymphoma [J]. Leuk Lymphoma, 2005, 46(11): 1553-1559.
  • 8Huang Q, Ai L, Zhang Z Y, et al. Promoter hypermethylation and protein expression of the P16 gene: analysis of 43 cases of B- cell primary gastric lymphomas from China[J]. Mod Pathol, 2004, 17(4): 416-422.
  • 9O'Brien SG, Deininger MW. Imatinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia. Semin Hematol, 2003,40 : 26-30.
  • 10Deininger MW, Goldman JM, Lydon N , et al . The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL- positive cells. Blood, 1997, 90:3691-3698.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部